FindMyKOL

Top experts by indication / Oncology

Most active experts in Kidney Cancer / RCC

2026 edition, data as of October 26, 2026

294 key opinion leaders in the directory are tagged to Kidney Cancer / RCC. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 223 of the 294 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1Brian RiniVanderbilt University Medical Center, TN18 trials
2Eric JonaschThe University of Texas MD Anderson Cancer Center, TX18 trials
3Robert MotzerMemorial Sloan Kettering Cancer Center, NY12 trials
4Sumanta PalCity of Hope, CA11 trials
5Walter StadlerCity of Hope, IL11 trials
6Toni ChoueiriDana-Farber Cancer Institute, MA8 trials
7Raquibul HannanUT Southwestern Medical Center, TX8 trials
8John HainsworthSarah Cannon Research Institute, TN7 trials
9Saby GeorgeRoswell Park Comprehensive Cancer Center, NY7 trials
10Leonard ApplemanUniversity of Pittsburgh, PA6 trials
11Nizar TannirThe University of Texas MD Anderson Cancer Center, TX6 trials
12Christopher RyanOR5 trials
13Ramaprasad SrinivasanMD5 trials
14Mehmet BilenEmory University, GA5 trials
15Ronald BukowskiCleveland Clinic, OH5 trials
16Rana McKayUniversity of California, San Diego, CA4 trials
17David McDermottBeth Israel Deaconess Medical Center, MA4 trials
18Sam WhitingWA4 trials
19Yasser GedJohns Hopkins University School of Medicine, MD4 trials
20Glenn LiuUniversity of Wisconsin Carbone Cancer Center, WI4 trials
21Brenda SandmaierFred Hutchinson Cancer Center, WA4 trials
22Matthew CampbellTX3 trials
23Moshe OrnsteinCleveland Clinic, OH3 trials
24Brian KushnerMemorial Sloan Kettering Cancer Center, NY3 trials
25Darren FeldmanMemorial Sloan Kettering Cancer Center, NY3 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 48 of the 294 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1Jeffrey SosmanNorthwestern University Feinberg School of Medicine, IL129,175 citations
2Toni ChoueiriDana-Farber Cancer Institute, MA128,964 citations
3Robert MotzerMemorial Sloan Kettering Cancer Center, NY124,725 citations
4Thomas WalshCornell University, NY105,956 citations
5Razelle KurzrockMedical College of Wisconsin, WI88,610 citations
6Brian RiniVanderbilt University Medical Center, TN78,561 citations
7Patrick HwuFL76,461 citations
8Joaquim BellmuntDana-Farber Cancer Institute67,263 citations
9Mitesh BoradMayo Clinic, AZ60,996 citations
10John HainsworthSarah Cannon Research Institute, TN58,030 citations
11Michael CarducciJohns Hopkins University School of Medicine, MD56,123 citations
12Naoto UenoUniversity of Hawaiʻi Cancer Center, HI49,693 citations
13Brenda SandmaierFred Hutchinson Cancer Center, WA36,879 citations
14Kim MargolinSaint John's Cancer Institute, CA35,896 citations
15Sumanta PalCity of Hope, CA34,788 citations
16Harriet KlugerYale School of Medicine, CT32,554 citations
17Nizar TannirThe University of Texas MD Anderson Cancer Center, TX32,130 citations
18Johanna BendellPfizer, TN30,947 citations
19David NanusWeill Cornell Medicine, NY30,130 citations
20Bonnie KyUniversity of Pennsylvania, PA27,426 citations
21Scott TagawaWeill Cornell Medicine, NY27,220 citations
22Primo LaraUniversity of California, Davis, CA26,914 citations
23Eric JonaschThe University of Texas MD Anderson Cancer Center, TX23,264 citations
24Saby GeorgeRoswell Park Comprehensive Cancer Center, NY22,167 citations
25Timothy KuzelNorthwestern University Feinberg School of Medicine, IL19,675 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 42 of the 294 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.

#Expertawards
1Bonnie KyUniversity of Pennsylvania, PA11 awards
2Brenda SandmaierFred Hutchinson Cancer Center, WA11 awards
3Harriet KlugerYale School of Medicine, CT11 awards
4Michael CarducciJohns Hopkins University School of Medicine, MD9 awards
5Toni ChoueiriDana-Farber Cancer Institute, MA7 awards
6David AviganDana-Farber Cancer Institute, MA7 awards
7Walter StadlerCity of Hope, IL6 awards
8Robert FiglinCedars-Sinai Medical Center, CA6 awards
9Primo LaraUniversity of California, Davis, CA6 awards
10Ronald BukowskiCleveland Clinic, OH6 awards
11David NanusWeill Cornell Medicine, NY5 awards
12Timothy KuzelNorthwestern University Feinberg School of Medicine, IL5 awards
13Naoto UenoUniversity of Hawaiʻi Cancer Center, HI4 awards
14David McDermottBeth Israel Deaconess Medical Center, MA4 awards
15David QuinnCA4 awards
16Jeffrey SosmanNorthwestern University Feinberg School of Medicine, IL4 awards
17Jacek PinskiUniversity of Southern California (USC), CA4 awards
18Glenn LiuUniversity of Wisconsin Carbone Cancer Center, WI3 awards
19Mitesh BoradMayo Clinic, AZ3 awards
20Rana McKayUniversity of California, San Diego, CA2 awards
21Robert MotzerMemorial Sloan Kettering Cancer Center, NY2 awards
22Barbara GitlitzUniversity of Southern California, CA2 awards
23Elizabeth FoxTN2 awards
24Raquibul HannanUT Southwestern Medical Center, TX2 awards
25Jennifer SpechtFred Hutchinson Cancer Center, WA2 awards

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 20 of the 294 people tagged to this indication have at least 2 registered trials in it and this count on record; the 20 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1Johanna BendellPfizer, TN310 contributions
2Nizar TannirThe University of Texas MD Anderson Cancer Center, TX278 contributions
3Primo LaraUniversity of California, Davis, CA264 contributions
4Siqing FuThe University of Texas MD Anderson Cancer Center, TX241 contributions
5Mehmet BilenEmory University, GA228 contributions
6John HainsworthSarah Cannon Research Institute, TN194 contributions
7Eric JonaschThe University of Texas MD Anderson Cancer Center, TX173 contributions
8Leonard ApplemanUniversity of Pittsburgh, PA125 contributions
9Saby GeorgeRoswell Park Comprehensive Cancer Center, NY115 contributions
10Jennifer SpechtFred Hutchinson Cancer Center, WA104 contributions
11Harriet KlugerYale School of Medicine, CT103 contributions
12Ana AparicioThe University of Texas MD Anderson Cancer Center, TX84 contributions
13Glenn LiuUniversity of Wisconsin Carbone Cancer Center, WI77 contributions
14Raquibul HannanUT Southwestern Medical Center, TX77 contributions
15David AviganDana-Farber Cancer Institute, MA74 contributions
16Roxana DroncaMayo Clinic, FL70 contributions
17Kim MargolinSaint John's Cancer Institute, CA68 contributions
18Timothy KuzelNorthwestern University Feinberg School of Medicine, IL57 contributions
19Bonnie KyUniversity of Pennsylvania, PA36 contributions
20Brenda SandmaierFred Hutchinson Cancer Center, WA32 contributions

Emerging

17 of the 294 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Ana AparicioThe University of Texas MD Anderson Cancer Center, TX
Fiyinfolu BalogunMemorial Sloan Kettering Cancer Center, NY
Jack BrzezinskiSeattle Children's Hospital, WA
Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX
Cathy EngVanderbilt University Medical Center, TN
Mayer FishmanTampa General Hospital, FL
Barbara GitlitzUniversity of Southern California, CA
Sangeeta GoswamiThe University of Texas MD Anderson Cancer Center, TX
Douglas HawkinsSeattle Children's Hospital, WA
Samir KhleifGeorgetown University School of Medicine, GA
Evan LipsonJohns Hopkins University School of Medicine, MD
Dustin McCurryThe University of Texas MD Anderson Cancer Center, TX
Yael MosseChildren's Hospital of Philadelphia, PA
Bilal OmerBaylor College of Medicine, TX
Wungki ParkMemorial Sloan Kettering Cancer Center, NY
Karie RuncieWeill Cornell Medicine, NY
Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX

How these tables are computed

The cohort is every profile in the directory tagged to Kidney Cancer / RCC, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Kidney Cancer / RCC profile in the directory